Table 2.

Number of patients receiving each therapy regimen

Target marrow dose from 166Ho-DOTMP
No melphalan
Melphalan, 140 mg/m2
Melphalan, 140 mg/m2 + TBI
Melphalan, 200 mg/m2
20Gy   0   5   6   4  
30Gy   0   4   9   7  
40Gy
 		 1
 		 7
 		 10
 		 30
 
Target marrow dose from 166Ho-DOTMP
No melphalan
Melphalan, 140 mg/m2
Melphalan, 140 mg/m2 + TBI
Melphalan, 200 mg/m2
20Gy   0   5   6   4  
30Gy   0   4   9   7  
40Gy
 		 1
 		 7
 		 10
 		 30
 
View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal